Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetWages, Salaries and Other
Ratios

Sutro Biopharma (STRO) Leases (2021 - 2025)

Sutro Biopharma (STRO) has disclosed Leases for 5 consecutive years, with $10.9 million as the latest value for Q4 2025.

  • Quarterly Leases fell 38.32% to $10.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.9 million through Dec 2025, down 38.32% year-over-year, with the annual reading at $10.9 million for FY2025, 38.32% down from the prior year.
  • Leases hit $10.9 million in Q4 2025 for Sutro Biopharma, down from $13.3 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $30.1 million in Q3 2021 to a low of $10.9 million in Q4 2025.
  • Historically, Leases has averaged $22.3 million across 5 years, with a median of $23.4 million in 2023.
  • Biggest five-year swings in Leases: decreased 8.95% in 2022 and later crashed 38.32% in 2025.
  • Year by year, Leases stood at $29.0 million in 2021, then fell by 8.95% to $26.4 million in 2022, then fell by 13.72% to $22.8 million in 2023, then dropped by 22.52% to $17.7 million in 2024, then plummeted by 38.32% to $10.9 million in 2025.
  • Business Quant data shows Leases for STRO at $10.9 million in Q4 2025, $13.3 million in Q3 2025, and $14.8 million in Q2 2025.